when does the patent for tirzepatide expire off retatrutide patent FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational tirzepatide patent expiry 2036 GLP-1 – Semaglutide & Tirzepatide Patent Considerations
Pay in 4 interest-free payments of $7.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1




























